Preclinical safety evaluation of biotechnology-derived pharmaceuticals

Joy Cavagnaro(Access to Wholistic and Productive Living Institute)
Nature Reviews Drug Discovery
June 1, 2002
10.1038/nrd822
Cited by 339

Abstract

Related Papers

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data
Jeremy K. Nicholson, John C. Lindon, Elaine Holmes|Xenobiotica|1999|3.9k
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
Jeffrey R. Botkin, John W. Belmont, Jonathan S. Berg et al.|The American Journal of Human Genetics|2015|895
Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes.
Fred D. Finkelman, Kathleen B. Madden, Suzanne C. Morris et al.|The Journal of Immunology|1993|361
Protein Aggregates Seem to Play a Key Role Among the Parameters Influencing the Antigenicity of Interferon Alpha (IFN-α) in Normal and Transgenic Mice
Andrea Braun, Lia Kwee, Mark Labow et al.|Pharmaceutical Research|1997|298
Antibodies chaperone circulating IL-6. Paradoxical effects of anti-IL-6 "neutralizing" antibodies in vivo.
Lauren T. May, R Neta, Lyle L. Moldawer et al.|The Journal of Immunology|1993|108